Public Company News

AMTD IDEA Group Achieved 150% Increase in Revenue for First Half in 2025

* AMTD IDEA Group Achieved ~150% Increase in Revenue * Total Net Income Surged 63.7% to US$68.8 million * Hospitality arm's revenue increased by over 60% * Total Assets amounted to US$2.193 billion (US$3.82/share) * Net asset value amounted to US$1,799 million (US$3.13/share)  PARIS and NE...

2025-12-30 21:30 11784

Nota AI to Supply AI Optimization Technology for Samsung Electronics' Next-Generation Mobile AP 'Exynos 2600'… Solidifying Its Position as a Leader in On-Device AI

* Secured consecutive contracts from Exynos 2500 to the next-generation Exynos 2600, proving the superior optimization capabilities * Advancing the next-generation version of 'Exynos AI Studio' and strengthening support for the latest Generative AI models SEOUL, South Korea, Dec. 30, 2025 /PR...

2025-12-30 21:00 3553

Delixy Holdings Limited Reports Unaudited Financial Results for the First Six Months of Fiscal Year 2025

SINGAPORE, Dec. 30, 2025 /PRNewswire/ -- Delixy Holdings Limited (Nasdaq: DLXY) (the "Company" or "Delixy"), aSingapore-based company engaged in the trading of oil related products, today announced its unaudited financial results for the six months endedJune 30, 2025. First Six Months of Fiscal ...

2025-12-30 19:00 10980

Euro Tech Holdings Company Limited Reports Interim Results For The Six Months Ended June 30, 2025

HONG KONG, Dec. 30, 2025 /PRNewswire/ -- Euro Tech Holdings Company Limited (Nasdaq: CLWT) today reported its unaudited financial results for the six months endedJune 30, 2025. The Company's revenue for the six months ended June 30, 2025 ("1H 2025") were US$5,888,000, a 18.9% decrease as compare...

2025-12-30 19:00 9867

New Oriental to Report Second Quarter 2026 Financial Results on January 28, 2026

BEIJING, Dec. 30, 2025 /PRNewswire/ -- New Oriental Education and Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services inChina, today announced that it will report its financial results for the second quarter endedNovember 30, ...

2025-12-30 17:00 3133

Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025's Largest Hong Kong Biotech IPO

HONG KONG, Dec. 30, 2025 /PRNewswire/ -- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully listed on the Hong Kong Stock Exchange today, becoming the first AI-driven biotech company to go public ...

2025-12-30 17:00 10418

Energy for All: SINEXCEL Turns Sustainability Commitments into Action

SHENZHEN, China, Dec. 30, 2025 /PRNewswire/ -- SINEXCEL (300693.SZ) has successfully concluded its two-month global ESG initiative, transforming its sustainability visionEnergy for All into meaningful, measurable action following the launch of i...

2025-12-30 16:00 4463

NAVER D2SF Invests in Sorcerics, an Ambient AI Startup Developing Autonomous AI Home Solutions

-Advances smart homes through Ambient AI that understands user context and delivers proactive services -Leverages a single camera and proprietary on-device LLMs to enhance privacy protection and product competitiveness -Targets the North American smart home market with a global product launch p...

2025-12-30 12:00 3850

Dr. Lu Xianping, Founder, Chairman of Chipscreen Biosciences named the Chinese mainland winner of the EY Entrepreneur Of The Year™ 2025 awards

SHENZHEN, China, Dec. 29, 2025 /PRNewswire/ -- On December 5, 2025, Dr. Lu Xianping, Founder, Chairman of Shenzhen Chipscreen Biosciences Co., Ltd, has been named the Chinese mainland winner of the EY Entrepreneur Of The Year™ 2025 awards.

2025-12-30 08:45 3726

Taoping Announces Transformational Growth Milestones: New Corporate Headquarters and US$2 Million Smart Infrastructure Contracts

TIANJIN, China, Dec. 29, 2025 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP) (the "Company"), a provider of innovative smart cloud platform services and solutions, today announced two significant strategic milestones underscoring its accelerating growth trajectory: the establishment of a new corpora...

2025-12-29 21:30 10498

Cloopen Announces Formation of Special Committee

BEIJING, Dec. 29, 2025 /PRNewswire/ -- Cloopen Group Holding Limited (OTC: RAASY) ("Cloopen" or the "Company") today announced that its Board of Directors (the "Board") has formed a special committee consisting of three independent directors, Mr.Adam J. Zhao, Mr. Tim Yimin Liu and Mr. Ziguang Gao...

2025-12-29 21:00 7207

ECARX Announces US$23 Million Strategic Investment in Lotus Technology to Deepen Global Partnership

LONDON, Dec. 29, 2025 /PRNewswire/ -- ECARX Holdings Inc. (Nasdaq: ECX) ("ECARX" or the "Company"), a global mobility tech provider, announced that it entered into a share subscription agreement (the "Subscription Agreement") on December 23, 2025, with Lotus Technology Inc. ("Lotus Tech") (Nasdaq:...

2025-12-29 20:00 9496

Lufax Announces Results of Extraordinary General Meeting

SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Lufax Holding Ltd (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners inChina, today announced the results of its extraordinary general meeting of shareholders held inShanghai on Dec 29, 2025. At the meeting, the follo...

2025-12-29 19:00 8108

iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results

BEIJING, Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products inChina, today announced its unaudited financial results for the third quarter endedSeptember 30, 2025. Third Quarter 2025 Highlights...

2025-12-29 17:11 6658

Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities

SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and more diverse therapeutic landscape. Viva Biotech has responded by building an integrated pharmacology pl...

2025-12-29 14:13 2732

XPENG-Peking University Collaborative Research Accepted by AAAI 2026: Introducing a Novel Visual Token Pruning Framework for Autonomous Driving

* XPENG-PKU Research Breakthrough: XPENG, in collaboration with Peking University, has developed FastDriveVLA—a novel visualtoken pruning framework that enables autonomous driving AI to "drive like a human" by focusing only on essential information, achieving a 7.5x reduction in computational l...

2025-12-29 13:35 3030

JinkoSolar Announces Results of 2025 Annual General Meeting

SHANGRAO, China, Dec. 29, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that all shareholders resolutions proposed at the Company's 2025 annual general ...

2025-12-29 13:13 2842

Senhwa Biosciences Aims at Multi-Billion Dollar Global Market with CX-5461 Combined with ADC "Blockbuster" Therapy

TAIPEI and SAN DIEGO, Dec. 28, 2025 /PRNewswire/ -- Following its recent clinical collaboration with the multinational pharmaceutical company BeOne Medicines to explore combination therapy with its marketed PD-1 inhibitor in the challenging field of cold tumor treatment, Senhwa Biosciences, Inc. ...

2025-12-29 10:24 2446

Harbour BioMed Enters into Long-Term Strategic Collaboration with Lannacheng to Advance Next-Generation Radionuclide Drug Conjugates

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Dec. 28, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced that it has entered into a l...

2025-12-29 09:58 1986

CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596

SHANGHAI, Dec. 28, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that it has submitted two separate Investigational New Drug (IND) applications to the National Medical Products Administr...

2025-12-29 08:10 1478
1 ... 3456789 ... 777